Angiotensin 1/2 (5-7): Assay Workflow
2026-09-25
Use Angiotensin 1/2 (5-7) to compare short renin–angiotensin system fragments in cardiovascular assays and in exploratory spike–receptor binding studies. This workflow separates the published binding result from practical starting conditions, with controls and troubleshooting to support interpretable experiments.
DiscoveryProbe Protease Inhibitor Library Workflows
2026-09-25
Use an 825-compound protease collection to map enzyme-linked phenotypes in biochemical and cell-based screens, then prioritize hits with orthogonal assays. This guide also explains how a recent bacterial DNA-defense study can sharpen assay design without implying that protease inhibitors directly target the DdmDE system.
Cytarabine (AraC): Practical Cell Assay Guide
2026-09-24
Use Cytarabine (AraC) to probe DNA synthesis, proliferation, and apoptosis in leukemia research, with dose and time-course design that separates early stress from later cell death. A careful comparison with RIPK3-focused viral research helps clarify what cytarabine assays can—and cannot—say about inflammatory cell death.
Angiotensin 1/2 (5-7): From RAS to Viral Binding
2026-09-24
Angiotensin 1/2 (5-7) connects renin-angiotensin system research with emerging evidence on SARS-CoV-2 spike–receptor binding. Explore the mechanistic findings, their translational limits, and practical considerations for studying this short peptide.
Pam3CSK4 TFA: A Practical TLR1/2 Assay Guide
2026-09-23
Use Pam3CSK4 TFA to isolate TLR1/2-driven innate responses in carefully controlled cell assays, then compare cytokine patterns with the receptor-stimulation findings reported in GBS-colonized pregnancies. This guide turns that translational question into a titration-first workflow, with practical handling and troubleshooting advice while distinguishing bench hypotheses from clinical evidence.
Dovitinib (TKI-258, CHIR-258) Assay Guide
2026-09-23
This scenario-based guide helps researchers design more interpretable viability, proliferation, and cytotoxicity assays with Dovitinib (TKI-258, CHIR-258), SKU A2168. It connects solvent handling, concentration planning, phospho-signaling readouts, apoptosis interpretation, and practical product-selection criteria to published and product-supported evidence.
Tunicamycin for ER Stress and UPR Research
2026-09-22
Tunicamycin is a practical N-glycosylation inhibitor for building controlled ER-stress models in macrophages and endothelial cells. This workflow connects glycosylation blockade with GRP78, ATF6, TRIM10, NF-κB, COX-2, and iNOS readouts while emphasizing dose selection, controls, and troubleshooting.
U 46619: Reliable TP-Receptor Assay Design
2026-09-22
Learn how U 46619 (SKU B6890) can standardize TP-receptor stimulation while helping researchers separate pathway-specific effects from solvent, handling, and cell-viability artifacts. This scenario-driven guide covers dose selection, compatibility, storage, interpretation, and practical vendor evaluation.
Sitagliptin Phosphate Monohydrate in Gut Assays
2026-09-21
Sitagliptin phosphate monohydrate is a selective DPP-4 inhibitor for dissecting incretin biology and glucose regulation. This article presents an assay strategy that separates pharmacological incretin hormone modulation from intestinal stretch signals revealed by recent metabolic research.
Tioconazole B2051: Reliable Assay Workflows
2026-09-21
Learn how Tioconazole (SKU B2051) can support controlled antifungal drug development, fungal infection models, and cell-based viability workflows. This scenario-based guide covers formulation, solvent controls, assay interpretation, storage, and vendor-selection considerations without overstating cross-domain evidence.
DNase I (RNase-free) for Long-RNA QC
2026-09-20
DNase I (RNase-free) is more than a cleanup reagent: it is a critical pre-analytical control for RNA extraction, IVT, RT-PCR, and long-RNA quality assessment. Learn how nuclease chemistry and duplex ddPCR design work together to distinguish DNA contamination from genuine RNA integrity.
MitMAB and the Logic of Endocytic Uptake Assays
2026-09-18
MitMAB enables mechanistic analysis of dynamin-dependent uptake in physiologically relevant models. This article connects intestinal organoid topology, milk-derived extracellular vesicle assays, and causal interpretation of endocytosis data.
Nanoparticle RNAi Delivery in Bemisia tabaci
2026-09-18
The 2026 study develops a C60/alkylpolyglucoside nanocarrier for delivering dsRNA against the Bemisia tabaci genes btCHS and btG6PI. Compared with dsRNA alone, the formulation improved target-gene suppression and reduced whitefly survival, supporting nanocarrier-assisted RNAi as a more effective crop-protection strategy while leaving field-scale performance to be established.
Lisinopril Dihydrate: From ACE Mechanism to Translation
2026-09-17
A mechanistic and strategic guide to using Lisinopril dihydrate as an ACE inhibitor in hypertension, cardiovascular, and renal research. The article connects target engagement, peptidase selectivity, assay design, product handling, and translational interpretation.
Network Medicine Identifies Apigenin for Alzheimer’s
2026-09-17
A 2025 study used network proximity analysis to screen 48 flavonoids against Alzheimer’s disease targets and identified Apigenin as the leading candidate. Integrated PC12 and BV2 cell experiments connected its neuroprotective activity with mitochondrial preservation, apoptosis control, AKT/NF-κB regulation, and modulation of microglial inflammatory states.